<ul><li>Alchemy, a healthcare company focused on improving access to medications for underserved populations, has secured $31M in seed funding led by Andreessen Horowitz (a16z) Bio + Health.</li><li>Alchemy provides infrastructure and technology to build and operate in-house pharmacy programs, primarily serving clinics with large HIV and HCV patient populations.</li><li>The funding will enable Alchemy to expand its reach and launch in-house pharmacy programs in 20 states, develop mobile clinic programs, and enhance its digital platform.</li><li>By partnering with Alchemy, clinics can increase access to essential medications, improve patient health outcomes, and optimize the financial sustainability of their pharmacy programs.</li></ul>

Alchemy Secures $31M to Expand In-House Pharmacy Programs for Underserved HIV Communities

Discover more